thymosin beta(4): Clinical Trials

7 trials of thymosin beta(4), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 withdrawn. 7 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Terminated 2, Withdrawn 1
Phase 31Completed 1

Follow thymosin beta(4): new trials by email Literature Review of thymosin beta(4) trials Research Report on thymosin beta(4)

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
Drug: Placebo, Drug: Injectable Thymosin beta 4 - Acute Myocardial Infarction, ST Elevation Myocardial Infarction
Phase 2WithdrawnRegeneRx Biopharmaceuticals, Inc.2019-07-012021-09-22
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
RGN-259, Placebo - Dry Eye Syndrome
Phase 2 / Phase 3CompletedReGenTree, LLC3172015-09-012019-10-17
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
Thymosin beta 4, Placebo - Dry Eye Syndrome, Dry Eye
Phase 2CompletedReGenTree, LLC722011-08-012015-07-10
A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds
Thymosin Beta 4 (Tβ4), Placebo - Diabetes
Phase 2TerminatedReGenTree, LLC122007-12-012015-07-08
Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers
Thymosin Beta 4, Placebo - Venous Stasis Ulcers
Phase 2CompletedRegeneRx Biopharmaceuticals, Inc.722006-07-012010-03-30
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
Placebo, Thymosin Beta 4 - Pressure Ulcers
Phase 2CompletedRegeneRx Biopharmaceuticals, Inc.722006-05-012010-02-01
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
Thymosin Beta 4, Placebo - Epidermolysis Bullosa
Phase 2TerminatedRegeneRx Biopharmaceuticals, Inc.302006-02-012014-05-12

Conditions studied

Dry Eye Syndromes (2)  ·  Diabetes Mellitus (1)  ·  Epidermolysis Bullosa (1)  ·  Leg Ulcer (1)  ·  Pressure Ulcer (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Varicose Ulcer (1)  ·  Venous Insufficiency (1)

Sponsors

RegeneRx Biopharmaceuticals, Inc. (4)  ·  ReGenTree, LLC (3)

Countries

United States (3)  ·  Italy (1)  ·  Poland (1)

Top investigators

David R Crockford (2)  ·  Gail Torkildsen, MD (2)  ·  Giorgio Guarnera, MD (1)  ·  J.J. Finkelstein, BBA (1)  ·  Terry Treadwell, MD (1)